{
  "meta": {
    "id": "test16",
    "title": "Pharmacology_DVT_Revision_Test",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A patient on cardiac medication, developed this complication (given in the ECG), For treating this problem, which one of the following is the suitable medication?",
      "options": [
        {
          "label": "A",
          "text": "Sotalol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Procainamide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Magnesium sulphate",
          "correct": true
        },
        {
          "label": "D",
          "text": "Dronedarone",
          "correct": false
        }
      ],
      "correct_answer": "C. Magnesium sulphate",
      "question_images": [
        "https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5103).png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 The immediate treatment for Torsades de Pointes, especially in a patient on cardiac medication, is intravenous Magnesium Sulfate. Magnesium acts as a calcium channel blocker and can stabilize the cardiac membrane, effectively suppressing TdP. Sotalol, Procainamide, and Dronedarone are antiarrhythmic drugs themselves and can cause or worsen TdP, making them unsuitable for treating this specific complication.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94496a6c",
      "audio": ""
    },
    {
      "text": "All of the following drugs causes adverse effects of agranulocytosis except",
      "options": [
        {
          "label": "A",
          "text": "Carbimazole",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tocainide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Clozapine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lithium",
          "correct": true
        }
      ],
      "correct_answer": "D. Lithium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Lithium is a mood stabilizer primarily used in the treatment of bipolar disorder. While lithium can cause a benign and reversible increase in white blood cell count (leukocytosis), it is not typically associated with agranulocytosis. Its side effect profile differs from the other drugs listed in this regard.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10a15100",
      "audio": ""
    },
    {
      "text": "A patient with Alzheimer disease needs treatment for overactive bladder (OAB). Which drug is the best choice for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Darifenacin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Solifenacin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tolterodine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trospium",
          "correct": true
        }
      ],
      "correct_answer": "D. Trospium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "79615ae6",
      "audio": ""
    },
    {
      "text": "Direct guanyl cyclase activator useful in primary pulmonary hypertension is",
      "options": [
        {
          "label": "A",
          "text": "Bosentan",
          "correct": false
        },
        {
          "label": "B",
          "text": "Riociguat",
          "correct": true
        },
        {
          "label": "C",
          "text": "Fasudil",
          "correct": false
        },
        {
          "label": "D",
          "text": "Iloprost",
          "correct": false
        }
      ],
      "correct_answer": "B. Riociguat",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Riociguat (option B) is a direct stimulator of soluble guanylate cyclase (sGC). Soluble guanylate cyclase is an enzyme in the nitric oxide (NO) signaling pathway. NO stimulates sGC, leading to increased production of cyclic guanosine monophosphate (cGMP), which promotes vasodilation and inhibits vascular smooth muscle proliferation. Riociguat directly activates sGC, independent of NO, and also sensitizes sGC to endogenous NO, thereby enhancing the NO-sGC-cGMP pathway. This action leads to relaxation of pulmonary vascular smooth muscle and is useful in treating pulmonary hypertension.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "85d53e3c",
      "audio": ""
    },
    {
      "text": "Apixaban action is reversed by",
      "options": [
        {
          "label": "A",
          "text": "Andexanet alpha",
          "correct": true
        },
        {
          "label": "B",
          "text": "Idaracizumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Avidin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Protamine sulfate",
          "correct": false
        }
      ],
      "correct_answer": "A. Andexanet alpha",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Andexanet alfa (option A) is a recombinant modified human Factor Xa decoy protein. It acts as a specific reversal agent for Factor Xa inhibitors like apixaban (and rivaroxaban) by binding to them, thereby sequestering the anticoagulant and allowing endogenous Factor Xa to resume its role in coagulation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6837fe7c",
      "audio": ""
    },
    {
      "text": "Which is the thiazide effective even in the presence of renal failure?",
      "options": [
        {
          "label": "A",
          "text": "Chlorthalidone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Metolazone",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hydrochlorothiazide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chlorthiazude",
          "correct": false
        }
      ],
      "correct_answer": "B. Metolazone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 However, among the thiazide-type diuretics, Metolazone (option B) is unique because it maintains its diuretic efficacy even in patients with moderate to severe renal impairment (low GFR). While it is structurally a quinazolinone derivative rather than a true thiazide, it is often grouped with thiazides due to its similar mechanism of action (inhibiting the Na+/Cl- cotransporter in the distal convoluted tubule) and clinical uses. Chlorthalidone, Hydrochlorothiazide, and Chlorothiazide are typical thiazide diuretics whose efficacy diminishes significantly in the presence of renal failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "90e73864",
      "audio": ""
    },
    {
      "text": "Match the following regarding adverse effects of cholesterol lowering agents",
      "options": [
        {
          "label": "A",
          "text": "1-C, 2-D, 3-B, 4-A",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-D, 2-D, 3-B, 4-A",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-D, 2-A, 3-B, 4-C",
          "correct": true
        },
        {
          "label": "D",
          "text": "1-B, 2-A, 3-D, 4-C",
          "correct": false
        }
      ],
      "correct_answer": "C. 1-D, 2-A, 3-B, 4-C",
      "question_images": [
        "https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5104).png"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c53e54cc",
      "audio": ""
    },
    {
      "text": "Which option is most appropriate for a patient with newly diagnosed hyperthyroidism in the first trimester of pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Methimazole",
          "correct": false
        },
        {
          "label": "B",
          "text": "Propylthiouracil (PTU)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Radioactive iodine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Surgical removal of thyroid",
          "correct": false
        }
      ],
      "correct_answer": "B. Propylthiouracil (PTU)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Propylthiouracil (PTU) (option B) is generally the preferred antithyroid drug during the first trimester of pregnancy. This is because methimazole, the other commonly used antithyroid drug, has been associated with a higher risk of teratogenic effects, specifically congenital malformations (e.g., aplasia cutis congenita, choanal atresia, esophageal atresia), if used during the first trimester. While PTU has its own risks (e.g., rare but severe hepatotoxicity), the risk of teratogenicity in the first trimester is considered lower than that of methimazole.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "52e61ba2",
      "audio": ""
    },
    {
      "text": "Match the following regarding antidiabetic drug and its site of",
      "options": [
        {
          "label": "A",
          "text": "1-B, 2-A, 3-D, 4-C",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-A, 2-C, 3-D, 4-A",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-D, 2-A, 3-B, 4-C",
          "correct": true
        },
        {
          "label": "D",
          "text": "1-C, 2-A, 3-D, 4-B",
          "correct": false
        }
      ],
      "correct_answer": "C. 1-D, 2-A, 3-B, 4-C",
      "question_images": [
        "https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5105).png"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ee24914c",
      "audio": ""
    },
    {
      "text": "Match the following regarding anti diabetic drug and its adverse effects",
      "options": [
        {
          "label": "A",
          "text": "1-D, 2-C, 3-B, 4-A",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-B, 2-D, 3-B, 4-A",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-C, 2-D, 3-A, 4-B",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-B, 2-C, 3-D, 4-A",
          "correct": true
        }
      ],
      "correct_answer": "D. 1-B, 2-C, 3-D, 4-A",
      "question_images": [
        "https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5106).png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 1. Exenatide is a GLP-1 receptor agonist. While generally well-tolerated, GLP-1 agonists, including exenatide, have been associated with a risk of pancreatitis (B). Patients should be advised to seek medical attention if they develop symptoms of pancreatitis (severe abdominal pain).</li><li>\u2022 2. Sitagliptin is a DPP-4 inhibitor. These drugs are generally well-tolerated, but common adverse effects include upper respiratory tract infections, such as nasopharyngitis (C).</li><li>\u2022 3. Dapagliflozin is an SGLT2 inhibitor. By promoting glucose excretion in the urine, SGLT2 inhibitors can lead to increased risk of genitourinary infections (e.g., vulvovaginal candidiasis, urinary tract infections) and volume depletion, which can cause hypotension (D).</li><li>\u2022 4. Pioglitazone is a thiazolidinedione (TZD). TZDs are known to increase the risk of fluid retention, which can lead to or worsen heart failure (A), especially in patients with pre-existing cardiac conditions. This is a significant contraindication and warning for this class of drugs.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "82bc1333",
      "audio": ""
    },
    {
      "text": "Mr. X is a patient with type 2 diabetes currently being treated with insulin detemir. The physician determines that Mr. X needs additional insulin therapy for control of postprandial glucose. Which agent is most appropriate to add at this time?",
      "options": [
        {
          "label": "A",
          "text": "Insulin degludec",
          "correct": false
        },
        {
          "label": "B",
          "text": "NPH insulin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Insulin lispro",
          "correct": true
        },
        {
          "label": "D",
          "text": "NPH/regular 70/30 insulin",
          "correct": false
        }
      ],
      "correct_answer": "C. Insulin lispro",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 To address postprandial glucose excursions, a rapid-acting insulin is typically added.</li><li>\u2022 Insulin lispro (C) is a rapid-acting insulin analog. It has a quick onset and a short duration of action, making it ideal for taking just before or with meals to cover the carbohydrate intake and control postprandial glucose levels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d2ecfc17",
      "audio": ""
    },
    {
      "text": "Match the following regarding SERM and its indication",
      "options": [
        {
          "label": "A",
          "text": "1-D, 2-C, 3-B, 4-A",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-B, 2-A, 3-D, 4-C",
          "correct": true
        },
        {
          "label": "C",
          "text": "1-C, 2-D, 3-A, 4-B",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-B, 2-C, 3-D, 4-A",
          "correct": false
        }
      ],
      "correct_answer": "B. 1-B, 2-A, 3-D, 4-C",
      "question_images": [
        "https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5107).png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 1. Ospemifene is a SERM primarily indicated for the treatment of moderate to severe dyspareunia (B) (painful intercourse) due to vulvar and vaginal atrophy, a symptom of menopausal vaginal dryness. It acts as an estrogen agonist on vaginal tissue.</li><li>\u2022 2. Ormiloxifene is a non-steroidal SERM used primarily as a non-hormonal, once-a-week oral contraceptive (A) in India. It works by interfering with implantation and having a mild estrogenic effect on the uterus.</li><li>\u2022 3. Clomiphene (Clomiphene citrate) is a well-known SERM used in the treatment of infertility (D) in women. It works by blocking estrogen receptors in the hypothalamus, which leads to increased secretion of GnRH, and subsequently FSH and LH from the pituitary, stimulating ovulation.</li><li>\u2022 4. Raloxifene is a SERM that acts as an estrogen agonist on bone and as an estrogen antagonist on breast and uterine tissue. Its primary indication is for the prevention and treatment of osteoporosis (C) in postmenopausal women, and it also reduces the risk of invasive breast cancer in certain high-risk postmenopausal women.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e08bc82d",
      "audio": ""
    },
    {
      "text": "Which one of the following monoclonal antibody useful in osteoporosis targeting against RANK-L?",
      "options": [
        {
          "label": "A",
          "text": "Burosumab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blosozumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Denosumab",
          "correct": true
        },
        {
          "label": "D",
          "text": "Romosozumab",
          "correct": false
        }
      ],
      "correct_answer": "C. Denosumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Denosumab (option C) is a fully human monoclonal antibody that specifically targets and binds to RANK-L. By doing so, it prevents RANK-L from binding to its receptor (RANK) on osteoclast precursors and mature osteoclasts. This inhibition leads to a decrease in osteoclast activity, thereby reducing bone resorption and increasing bone mineral density. It is widely used for the treatment of osteoporosis, particularly in postmenopausal women at high risk of fracture.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "13bf7fb0",
      "audio": ""
    },
    {
      "text": "A 55-year-old teacher was diagnosed with depression. After 6 weeks of therapy with fluoxetine, his symptoms improved, but he complains of sexual dysfunction. Which of the following drugs might be useful for management of depression in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Sertraline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Citalopram",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mirtazapine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lithium",
          "correct": false
        }
      ],
      "correct_answer": "C. Mirtazapine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Mirtazapine (C) is an atypical antidepressant that works by blocking \u03b12\u200b-adrenergic autoreceptors, leading to increased release of norepinephrine and serotonin. It also blocks 5-HT2 and 5-HT3 serotonin receptors. Unlike SSRIs, mirtazapine is generally associated with a very low incidence of sexual dysfunction. This makes it a suitable alternative for patients experiencing this particular side effect with SSRIs.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b7f7b940",
      "audio": ""
    },
    {
      "text": "Which one of the following drug useful for treating opioid poisoning as well as useful in prevention of relapse of opioid habit?",
      "options": [
        {
          "label": "A",
          "text": "Acamprostate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Naltrexone",
          "correct": true
        },
        {
          "label": "C",
          "text": "Naloxone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Alvimopan",
          "correct": false
        }
      ],
      "correct_answer": "B. Naltrexone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Naltrexone (B) fits this description. It is a long-acting opioid receptor antagonist.</li><li>\u2022 For opioid poisoning (overdose): While not typically the first-line for acute overdose due to its slower onset compared to naloxone, high doses of naltrexone can reverse opioid effects. However, its primary role in acute overdose is limited because its duration of action is longer than most short-acting opioids, which can lead to recurrent respiratory depression if not properly managed.</li><li>\u2022 For prevention of relapse: Naltrexone is very effective in preventing relapse for both opioid use disorder and alcohol use disorder. It blocks the euphoric and reinforcing effects of opioids, reducing cravings and preventing the \"high\" if opioids are used. It's available in oral and long-acting injectable formulations for this purpose.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "02a320ed",
      "audio": ""
    },
    {
      "text": "Which one of the following drug useful in bronchial asthma targeting against IL-4?",
      "options": [
        {
          "label": "A",
          "text": "Tralokinumab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dupilumab",
          "correct": true
        },
        {
          "label": "C",
          "text": "Fevipiprant",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mometasone",
          "correct": false
        }
      ],
      "correct_answer": "B. Dupilumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Dupilumab (B) is a monoclonal antibody that specifically targets the alpha subunit of the IL-4 receptor (IL-4R$\\alpha$). This receptor subunit is shared by both IL-4 and IL-13, meaning that dupilumab effectively blocks signaling from both IL-4 and IL-13. By inhibiting the action of these two critical cytokines, dupilumab reduces type 2 inflammation and is highly effective in treating severe eosinophilic asthma and atopic dermatitis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2a55d063",
      "audio": ""
    },
    {
      "text": "Which one of the following is responsible for this adverse effect (heterochromia iridis) shown in the image?",
      "options": [
        {
          "label": "A",
          "text": "Tamoxifen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Amiodarone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Latanoprost",
          "correct": true
        },
        {
          "label": "D",
          "text": "Erlotinib",
          "correct": false
        }
      ],
      "correct_answer": "C. Latanoprost",
      "question_images": [
        "https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/1(1203).png"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "53bf18ec",
      "audio": ""
    },
    {
      "text": "VGFR blocker approved for treatment of wet ARMD is",
      "options": [
        {
          "label": "A",
          "text": "Ocriplasmin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pegaptanib",
          "correct": true
        },
        {
          "label": "C",
          "text": "Netarsudil",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sunitinib",
          "correct": false
        }
      ],
      "correct_answer": "B. Pegaptanib",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Pegaptanib (B) (brand name Macugen) was one of the first anti-VEGF agents approved for the treatment of wet ARMD. It is a pegylated aptamer that specifically binds to and inhibits the activity of VEGF-165, an isoform of VEGF strongly implicated in pathological angiogenesis in the eye. While newer, broader anti-VEGF agents (like ranibizumab, aflibercept, and faricimab) are now more commonly used, pegaptanib was a pioneer VGFR blocker for this condition.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4a17dabd",
      "audio": ""
    },
    {
      "text": "Which one of the following agent increases intestinal chloride secretion by activating guanyl cyclase C?",
      "options": [
        {
          "label": "A",
          "text": "Bisacodyl",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lubiprostone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Linaclotide",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lactulose",
          "correct": false
        }
      ],
      "correct_answer": "C. Linaclotide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Linaclotide (C) is a guanylate cyclase-C (GC-C) agonist. It binds to and activates GC-C receptors on the luminal surface of intestinal epithelial cells. This activation leads to an increase in intracellular cyclic guanosine monophosphate (cGMP), which in turn stimulates the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel, leading to increased chloride and bicarbonate secretion into the intestinal lumen. This increased secretion of ions draws water into the lumen, increasing intestinal fluid and accelerating transit.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d222268e",
      "audio": ""
    },
    {
      "text": "An alcoholic male has developed hepatic cirrhosis. To control the ascites and edema, which should be prescribed?",
      "options": [
        {
          "label": "A",
          "text": "Acetazolamide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chlorthalidone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Spironolactone",
          "correct": true
        }
      ],
      "correct_answer": "D. Spironolactone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Spironolactone (D) is an aldosterone antagonist and a potassium-sparing diuretic. It directly counteracts the effects of aldosterone, blocking sodium reabsorption and promoting sodium and water excretion, while conserving potassium. This makes it the first-line and most effective diuretic for controlling ascites and edema in cirrhosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7990d6d7",
      "audio": ""
    },
    {
      "text": "A 3 year old child presented to the OPD with the symptom of influenza. Aspirin is contraindicated in this patient because of increased risk of :",
      "options": [
        {
          "label": "A",
          "text": "Gastric bleeding",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thrombocytopenia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fanconi syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reye\u2019s syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Reye\u2019s syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "158bb2b3",
      "audio": ""
    },
    {
      "text": "Dapsone is used for treatment of bacterial and fungal infections as well as for immunomodulatory actions. What is mechanism of dapsone for these indications?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of cell wall synthesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inhibition of ergosterol in cell membranes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inhibition of protein synthesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Competition with PABA in folic acid synthesis",
          "correct": true
        }
      ],
      "correct_answer": "D. Competition with PABA in folic acid synthesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Dapsone (option D) works by competing with para-aminobenzoic acid (PABA) in folic acid synthesis. Bacteria (and some fungi) synthesize their own folic acid, which is essential for DNA and RNA synthesis. Dapsone is a structural analog of PABA and competitively inhibits dihydropteroate synthase, an enzyme involved in the conversion of PABA to dihydrofolic acid. This disruption of the folate pathway leads to inhibition of bacterial growth (bacteriostatic action).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7ee6c50",
      "audio": ""
    },
    {
      "text": "Pediatrician was called for attending a new born baby. The serum unconjugated bilirubin of this baby was 33 mg/dl. Which of the following drug taken by mother in late 3rd trimester may have lead to this problem?",
      "options": [
        {
          "label": "A",
          "text": "Cotrimoxazole",
          "correct": true
        },
        {
          "label": "B",
          "text": "Azithromycin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ampicillin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chloroquine",
          "correct": false
        }
      ],
      "correct_answer": "A. Cotrimoxazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 Cotrimoxazole (A), which is a combination of trimethoprim and sulfamethoxazole (a sulfonamide), is known to displace bilirubin from albumin binding sites. If taken by the mother in the late third trimester, the sulfonamide component can lead to significantly elevated free unconjugated bilirubin levels in the neonate, increasing the risk of kernicterus. Therefore, sulfonamides are generally avoided in late pregnancy and in newborns.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f34e2acc",
      "audio": ""
    },
    {
      "text": "A young female is on anti- epileptic drugs since 6 months. She had no episode of seizure after starting the drug therapy. EEG and brain CT scan is normal. What should be the further management of this girl?",
      "options": [
        {
          "label": "A",
          "text": "Gradually taper the treatment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Continue the treatment of minimum 2 years",
          "correct": true
        },
        {
          "label": "C",
          "text": "Continue treatment life long",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stop treatment and follow up with regular EEG monitoring",
          "correct": false
        }
      ],
      "correct_answer": "B. Continue the treatment of minimum 2 years",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 While some patients may eventually be able to discontinue AEDs, 6 months of seizure freedom is generally considered too short a period to safely taper the medication. The risk of recurrence is still relatively high at this point. Guidelines often suggest a seizure-free period of at least 2-5 years, depending on the seizure type, etiology, and other risk factors, before considering a gradual taper. Continuing treatment lifelong (C) is usually reserved for patients with a very high risk of recurrence or specific epilepsy syndromes. Stopping treatment abruptly (D) is dangerous due to the risk of seizure recurrence or even status epilepticus. A gradual taper (A) is the correct approach when discontinuation is deemed appropriate, but not after only 6 months of seizure freedom.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eadc6bf4",
      "audio": ""
    },
    {
      "text": "Which of the following is correct regarding the mechanism of action of thyroid hormones T4 and T3 at thyroid hormone receptor?",
      "options": [
        {
          "label": "A",
          "text": "These activate GPCR",
          "correct": false
        },
        {
          "label": "B",
          "text": "These act by ionotrophic receptor",
          "correct": false
        },
        {
          "label": "C",
          "text": "These activate a tyrosine kinase enzyme",
          "correct": false
        },
        {
          "label": "D",
          "text": "These activate a nuclear receptor transcription factor",
          "correct": true
        }
      ],
      "correct_answer": "D. These activate a nuclear receptor transcription factor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>\u2022 The mechanism of action of thyroid hormones involves activating nuclear receptor transcription factors (D). Once inside the cell, T4 is mostly converted to the more active T3. T3 then binds to specific thyroid hormone receptors (TRs) located in the nucleus. These TRs are part of the nuclear receptor superfamily, which also includes steroid hormone receptors. When T3 binds to its receptor, the hormone-receptor complex then binds to specific DNA sequences called thyroid hormone response elements (TREs) in the promoter regions of target genes. This binding modulates gene transcription, leading to changes in the synthesis of various proteins that mediate the diverse physiological effects of thyroid hormones.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "88390227",
      "audio": ""
    }
  ]
}